| Product Code: ETC9202278 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Antimicrobial Resistance Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Serbia Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Serbia Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Serbia Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Serbia Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Serbia Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Serbia Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in antibiotic resistance rates in Serbia |
4.2.2 Growing awareness about the threat of antimicrobial resistance |
4.2.3 Government initiatives to address antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 Lack of standardized guidelines for antibiotic use |
4.3.3 High cost associated with developing new antimicrobial drugs |
5 Serbia Antimicrobial Resistance Market Trends |
6 Serbia Antimicrobial Resistance Market, By Types |
6.1 Serbia Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Serbia Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Serbia Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Serbia Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Serbia Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Serbia Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Serbia Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Serbia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Serbia Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Serbia Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Serbia Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Serbia Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Serbia Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Serbia Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Serbia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Serbia Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Serbia Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Serbia Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Serbia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Serbia Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Serbia Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Serbia Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Serbia Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Serbia Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Serbia Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Serbia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Serbia Antimicrobial Resistance Market Export to Major Countries |
7.2 Serbia Antimicrobial Resistance Market Imports from Major Countries |
8 Serbia Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of hospitals in Serbia implementing antimicrobial stewardship programs |
8.2 Number of research studies conducted on antimicrobial resistance in Serbia |
8.3 Rate of adoption of rapid diagnostic tests for antimicrobial susceptibility testing in healthcare facilities |
9 Serbia Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Serbia Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Serbia Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Serbia Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Serbia Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Serbia Antimicrobial Resistance Market - Competitive Landscape |
10.1 Serbia Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Serbia Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here